IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection
Open Access
- 10 March 2008
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 205 (3), 533-541
- https://doi.org/10.1084/jem.20071948
Abstract
Therapeutic vaccination is a potentially powerful strategy to establish immune control and eradicate persistent viral infections. Large and multifunctional antiviral T cell responses are associated with control of viral persistence; however, for reasons that were mostly unclear, current therapeutic vaccination approaches to restore T cell immunity and control viral infection have been ineffective. Herein, we confirmed that neutralization of the immunosuppressive factor interleukin (IL)-10 stimulated T cell responses and improved control of established persistent lymphocytic choriomeningitis virus (LCMV) infection. Importantly, blockade of IL-10 also allowed an otherwise ineffective therapeutic DNA vaccine to further stimulate antiviral immunity, thereby increasing T cell responses and enhancing clearance of persistent LCMV replication. We therefore propose that a reason that current therapeutic vaccination strategies fail to resurrect/sustain T cell responses is because they do not alleviate the immunosuppressive environment. Consequently, blocking key suppressive factors could render ineffective vaccines more efficient at improving T cell immunity, and thereby allow immune-mediated control of persistent viral infection.Keywords
This publication has 33 references indexed in Scilit:
- Enhancing therapeutic vaccination by blocking PD-1–mediated inhibitory signals during chronic infectionThe Journal of Experimental Medicine, 2008
- Interleukin-10 determines viral clearance or persistence in vivoNature Medicine, 2006
- Resolution of a chronic viral infection after interleukin-10 receptor blockadeThe Journal of Experimental Medicine, 2006
- Gender Susceptibility to Chronic Hepatitis C Virus Infection Associated with Interleukin 10 Promoter PolymorphismJournal of Virology, 2006
- Association between chronic hepatitis B virus infection and interleukin‐10, tumor necrosis factor‐α gene promoter polymorphismsJournal of Gastroenterology and Hepatology, 2006
- Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infectionJournal of Clinical Investigation, 2006
- Intrinsic Functional Dysregulation of CD4 T Cells Occurs Rapidly following Persistent Viral InfectionJournal of Virology, 2005
- Low CD8 T-Cell Proliferative Potential and High Viral Load Limit the Effectiveness of Therapeutic VaccinationJournal of Virology, 2005
- Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10Proceedings of the National Academy of Sciences, 2000
- Polymorphism of the Interleukin‐10 Gene Is Associated with Susceptibility to Epstein‐Barr Virus InfectionThe Journal of Infectious Diseases, 1999